NCT06788938
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06788938
Title Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jonsson Comprehensive Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC Davis Comprehensive Cancer Center NOT_YET_RECRUITING Davis California 95817 United States Details
UCI Health Chao Family Comprehensive Cancer Center NOT_YET_RECRUITING Irvine California 92612 United States Details
University of California at Los Angeles RECRUITING Los Angeles California 90095 United States Details
UC San Diego Moores Cancer Center NOT_YET_RECRUITING San Diego California 92093 United States Details
University of California at San Francisco NOT_YET_RECRUITING San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field